Cargando…

Myosteatosis Differentially Affects the Prognosis of Non-Metastatic Colon and Rectal Cancer Patients: An Exploratory Study

Body composition performed by computed tomography (CT) impacts on cancer patients’ prognoses and responses to treatment. Myosteatosis has been related to overall survival (OS) and disease-specific survival in colorectal cancer (CRC); however, the independent impact of the association of myosteatosis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pozzuto, Lara, Silveira, Marina Nogueira, Mendes, Maria Carolina Santos, Macedo, Lígia Traldi, Costa, Felipe Osório, Martinez, Carlos Augusto Real, Coy, Cláudio Saddy Rodrigues, da Cunha Júnior, Ademar Dantas, Carvalheira, José Barreto Campello
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632142/ https://www.ncbi.nlm.nih.gov/pubmed/34858841 http://dx.doi.org/10.3389/fonc.2021.762444

Ejemplares similares

Association of Albumin-Corrected Serum Calcium Levels with Colorectal Cancer Survival Outcomes
por: Silveira, Marina Nogueira, et al.
Publicado: (2022)

Myosteatosis in a systemic inflammation‐dependent manner predicts favorable survival outcomes in locally advanced esophageal cancer
por: Gabiatti, Camila T. B., et al.
Publicado: (2019)

Repurposing metformin for the treatment of gastrointestinal cancer
por: Cunha Júnior, Ademar Dantas, et al.
Publicado: (2021)

Myosteatosis and nlr as predictors of poor outcomes in patients with Covid-19
por: Padilha, D.M.D.H., et al.
Publicado: (2021)

Metformin and blood cancers
por: Cunha Júnior, Ademar Dantas, et al.
Publicado: (2018)

Obesity as a Possible Risk Factor for Progression from Monoclonal Gammopathy of Undetermined Significance Progression into Multiple Myeloma: Could Myeloma Be Prevented with Metformin Treatment?
por: da Cunha Júnior, Ademar Dantas, et al.
Publicado: (2021)

Plasma Lipidomic Signature of Rectal Adenocarcinoma Reveals Potential Biomarkers
por: Fernandes Messias, Márcia Cristina, et al.
Publicado: (2018)

Computed Tomography-Derived Myosteatosis and Metabolic Disorders
por: Miljkovic, Iva, et al.
Publicado: (2021)

Clinical Relevance of Myopenia and Myosteatosis in Colorectal Cancer
por: Okugawa, Yoshinaga, et al.
Publicado: (2022)

High prevalence of sarcopenia and myosteatosis in patients undergoing hemodialysis
por: Fu, Chen, et al.
Publicado: (2023)

Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis
por: Montano‐Loza, Aldo J., et al.
Publicado: (2015)

Pelvic muscle size and myosteatosis: Relationship with age, gender, and obesity
por: Pacicco, Thomas, et al.
Publicado: (2019)

Psoriasis Is Associated With Myosteatosis but Not Sarcopenia: A Case-Control Study
por: Chen, Xiaomei, et al.
Publicado: (2021)

Impact of myopenia and myosteatosis on postoperative outcome and recurrence in Crohn’s disease
por: Pozios, Ioannis, et al.
Publicado: (2022)

Myosteatosis predicting risk of transition to severe COVID-19 infection
por: Yi, Xiaoping, et al.
Publicado: (2022)

Prognostic Impact of Myosteatosis on Mortality in Hospitalized Patients with COVID-19
por: Kang, Min-Kyu, et al.
Publicado: (2022)

Effects of sarcopenia and myosteatosis are alleviated in reduced port surgery for diverticulitis
por: Schaffler-Schaden, Dagmar, et al.
Publicado: (2023)

Low skeletal muscle radiodensity and neutrophil-to-lymphocyte ratio as predictors of poor outcome in patients with COVID-19
por: Padilha, Daniela M. H., et al.
Publicado: (2022)

Myosteatosis is associated with poor physical fitness in patients undergoing hepatopancreatobiliary surgery
por: West, Malcolm A., et al.
Publicado: (2019)

The impact of sarcopenia and myosteatosis on postoperative outcomes in patients with inflammatory bowel disease
por: O’Brien, Stephen, et al.
Publicado: (2018)

Myosteatosis in Cirrhosis: A Review of Diagnosis, Pathophysiological Mechanisms and Potential Interventions
por: Ebadi, Maryam, et al.
Publicado: (2022)

The Impact of Myosteatosis Percentage on Short-Term Mortality in Patients with Septic Shock
por: Kim, June-sung, et al.
Publicado: (2022)

Myosteatosis as a Shared Biomarker for Sarcopenia and Cachexia Using MRI and Ultrasound
por: Lortie, Jevin, et al.
Publicado: (2022)

Prognostic Value of Sarcopenia and Myosteatosis in Patients with Resectable Pancreatic Ductal Adenocarcinoma
por: Kim, Dong Wook, et al.
Publicado: (2022)

Myosteatosis as a prognostic factor of Mycobacterium avium complex pulmonary disease
por: Chung, Eunki, et al.
Publicado: (2023)

Addition of bevacizumab to first-line chemotherapy in advanced colorectal cancer: a systematic review and meta-analysis, with emphasis on chemotherapy subgroups
por: Macedo, Ligia Traldi, et al.
Publicado: (2012)

Intracellular hyaluronic acid-binding protein 4 (HABP4): a candidate tumor suppressor in colorectal cancer
por: Melo-Hanchuk, Talita Diniz, et al.
Publicado: (2020)

Impact of androgen deprivation therapy on mortality of prostate cancer patients with COVID-19: a propensity score-based analysis
por: Duarte, Mateus Bringel Oliveira, et al.
Publicado: (2021)

Outcomes of COVID-19 Patients under Cytotoxic Cancer Chemotherapy in Brazil
por: Duarte, Mateus Bringel Oliveira, et al.
Publicado: (2020)

Sarcopenia and myosteatosis are accompanied by distinct biological profiles in patients with pancreatic and periampullary adenocarcinomas
por: Stretch, Cynthia, et al.
Publicado: (2018)

Effects of vitamin D on insulin resistance and myosteatosis in diet-induced obese mice
por: Benetti, Elisa, et al.
Publicado: (2018)

Sarcopenia and Myosteatosis at Presentation Adversely Affect Survival After Esophagectomy for Esophageal Cancer
por: Srpcic, Matevz, et al.
Publicado: (2020)

Myosteatosis as a novel prognostic biomarker after radical cystectomy for bladder cancer
por: Yamashita, Shimpei, et al.
Publicado: (2020)

Sarcopenia and Myosteatosis as Prognostic Markers in Patients with Advanced Cholangiocarcinoma Undergoing Palliative Treatment
por: Jördens, Markus S., et al.
Publicado: (2021)

Myosteatosis Significantly Predicts Persistent Dyspnea and Mobility Problems in COVID-19 Survivors
por: De Lorenzo, Rebecca, et al.
Publicado: (2022)

Corrigendum: Myosteatosis as a Shared Biomarker for Sarcopenia and Cachexia Using MRI and Ultrasound
por: Lortie, Jevin, et al.
Publicado: (2022)

Myosteatosis Is Not Associated with Complications or Survival in HCC Patients Undergoing Trans Arterial Embolization
por: Masetti, Chiara, et al.
Publicado: (2022)

The effect of computed tomography parameters on sarcopenia and myosteatosis assessment: a scoping review
por: Lortie, Jevin, et al.
Publicado: (2022)

Myosteatosis and bone marrow adiposity are not associated among postmenopausal women with fragility fractures
por: Badr, Sammy, et al.
Publicado: (2023)

Variability in Myosteatosis and Insulin Resistance Induced by High-Fat Diet in Mouse Skeletal Muscles
por: Collino, Massimo, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_fmnlt453r98cb5b853snujraku